Opioids, antidepressants and adverse events in nursing homes


Pharmacists can provide valuable input for clinicians when it comes to the use of antidepressants and certain opioids, one expert says Researchers set out to investigate the concomitant use of CYP2D6-metabolised opioids and antidepressants with clinical outcomes and opioid-related adverse events The target trial emulation study, published in the Annals of Internal Medicine, found that

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Leaders lauded
Next Dispensing dwindles in the Depression